Daxor
4 hedge funds and large institutions have $690K invested in Daxor in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
15% more capital invested
Capital invested by funds: $601K → $690K (+$88.4K)
0.07% less ownership
Funds ownership: 1.62% → 1.55% (-0.07%)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$18.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.52K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$9 |
DXR Hedge Fund Activity: Q1 2023 in Review
4 of the 6,285 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2023, worth a combined $690K — up 15% from $601K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $18.4K.
- 4 institutional investors held Daxor (DXR) as of Q1 2023, down from 5 in Q4 2022.
- Funds reported $690K of Daxor stock for Q1 2023, up 15% quarter-over-quarter.
- 0 funds opened new Daxor positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest Daxor seller in Q1 2023 was Renaissance Technologies, an estimated $18.4K sold.
Based on aggregated 13F filings for Q1 2023.